These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16584581)
1. [Expression of the transcription factor PAX5 in childhood acute leukemic cells]. Zhang B; Tie LJ; Ye QD; Gu LJ; Tang JY; Yuan XL; Shen LS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):6-10. PubMed ID: 16584581 [TBL] [Abstract][Full Text] [Related]
2. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5. Walter K; Cockerill PN; Barlow R; Clarke D; Hoogenkamp M; Follows GA; Richards SJ; Cullen MJ; Bonifer C; Tagoh H Oncogene; 2010 May; 29(20):2927-37. PubMed ID: 20208555 [TBL] [Abstract][Full Text] [Related]
4. Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma. Bharti B; Shukla S; Tripathi R; Mishra S; Kumar M; Pandey M; Mishra R Indian J Med Res; 2016 May; 143(Supplement):S23-S31. PubMed ID: 27748274 [TBL] [Abstract][Full Text] [Related]
5. A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. Bousquet M; Broccardo C; Quelen C; Meggetto F; Kuhlein E; Delsol G; Dastugue N; Brousset P Blood; 2007 Apr; 109(8):3417-23. PubMed ID: 17179230 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia. Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177 [TBL] [Abstract][Full Text] [Related]
7. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children. Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225 [TBL] [Abstract][Full Text] [Related]
8. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells. Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310 [TBL] [Abstract][Full Text] [Related]
9. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22). Johnson RC; Ma L; Cherry AM; Arber DA; George TI Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454 [TBL] [Abstract][Full Text] [Related]
10. [Effect of pax5 gene blocked by RNAi on biological characteristics of B cell malignant lymphoma]. Yuan XL; Zhang B; Jiang LM; Shen LS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):799-803. PubMed ID: 18718064 [TBL] [Abstract][Full Text] [Related]
11. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032 [TBL] [Abstract][Full Text] [Related]
12. Altered mRNA expression of PAX5 is a common event in acute lymphoblastic leukaemia. Santoro A; Bica MG; Dagnino L; Agueli C; Salemi D; Cannella S; Veltroni M; Cetica V; Giarin E; Fabbiano F; Basso G; Arico M Br J Haematol; 2009 Sep; 146(6):686-9. PubMed ID: 19604238 [No Abstract] [Full Text] [Related]
13. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia. Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623 [TBL] [Abstract][Full Text] [Related]
14. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22). Valbuena JR; Medeiros LJ; Rassidakis GZ; Hao S; Wu CD; Chen L; Lin P Am J Clin Pathol; 2006 Aug; 126(2):235-40. PubMed ID: 16891199 [TBL] [Abstract][Full Text] [Related]
15. Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia. Best A; Matheson E; Minto L; Hall AG; Irving JA Leuk Res; 2010 Aug; 34(8):1098-102. PubMed ID: 20233627 [TBL] [Abstract][Full Text] [Related]
16. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546 [TBL] [Abstract][Full Text] [Related]
17. Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma. Bharti B; Mishra R Biochim Biophys Acta; 2011 Dec; 1813(12):2071-8. PubMed ID: 21854813 [TBL] [Abstract][Full Text] [Related]
18. [The expression of CD19 in 210 cases of childhood acute leukemia and its significance]. Chen YH; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Qian BQ; Xu WQ; Ning BT Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):188-91. PubMed ID: 15144712 [TBL] [Abstract][Full Text] [Related]